ABCG1 and morbid obesity: In conclusion, the results of this pilot study identify, for the first time, significant associations between genetic dysregulation of hepatic lipid metabolism involving the CROT and ABCG1 genes and the presence of DD symptoms in patients with morbid obesity and implicated MASLD risk.